Dosage Options
Dosage Options
Dosage forms & strengths
ELIGARD provides flexible dosing options with technology that enables small injection volumes. [1]
The injection delivers the dose of leuprolide acetate incorporated in a polymer formulation.
| 7.5 mg (every month) | 22.5 mg (every 3-months) | 30 mg (every 4-months) | 45 mg (every 6-months) | |
| Injection Volume | 0.25 mL | 0.375 mL | 0.50 mL | 0.375 mL |
| Mean serum testosterone level at study conclusion* | 6.1 ng/dL | 10.1 ng/dL | 12.4 ng/dL | 12.6 ng/dL |
| Mean PSA reduction | 94% | 98% | 86% | 97% |
ELIGARD® is an injectable suspension of leuprolide acetate available in a single- dose kit. The kit consists of two prefilled syringes whose contents are mixed immediately prior to administration.
The kit also contains a sterile safety needle (Table 1), a desiccant, and a package insert for reconstitution and administration procedures.
| ELIGARD strength | Gauge | Length |
|---|---|---|
| 7.5 mg (1 injection every month) | 20-gauge | 5/8-inch |
| 22.5 mg (1 injection every 3-months) | 20-gauge | 5/8-inch |
| 30 mg (1 injection every 4-months) | 20-gauge | 5/8-inch |
| 45 mg (1 injection every 6-months) | 18-gauge | 5/8-inch |
See Mixing & Administration for full details.
References
- ELIGARD® (leuprolide acetate) for injectable suspension 7.5 mg, 22.5 mg, 30 mg, 45 mg prescribing information. Fort Collins, CO: Tolmar Therapeutics, Inc.; 2019.